Stage IIIB Breast Cancer Completed Phase 1 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01251874Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment
NCT01281150Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsTreatment